Browse > Article

Comparison of Clinical Progress between Single- and Multiple-dose Surfactant Treatment in Neonatal Respiratory Distress Syndrome  

Kil, Chang Hee (Department of Pediatrics, College of Medicine, Kyunghee University)
Jeon, Ho Sang (Department of Pediatrics, College of Medicine, Kyunghee University)
Bae, Chong Woo (Department of Pediatrics, College of Medicine, Kyunghee University)
Publication Information
Clinical and Experimental Pediatrics / v.48, no.10, 2005 , pp. 1090-1095 More about this Journal
Abstract
Purpose : In the case of serious respiratory distress syndrome(RDS) or relapse of clinical appearances after single treatment, we obtained more effective results with multiple-dose surfactant replacement therapy. We carried out this investigation for comparing and observing clinical progress between single-dose(group S) and multiple-dose(group M) pulmonary surfactant treatment group of neonatal RDS. Methods : We investigated 48 neonates who were diagnosed as RDS and treated with pulmonary surfactant(PS) replacement therapy in NICU of Kyunghee University hospital from January 2002 to March 2004, then we compared and verified clinical progress of 32 neonates in group S with that of 16 neonates in group M. Results : There were no significant statistical differences in average birth weights, average gestational periods, initial pH values of birth, whether operation of resuscitation at that time of birth was made or not, whether prenatal steroid prescription for mother, RDS classification standardized by Bomsel, and ventilation index(VI) before instillation of PS of two groups. However, there was significant statistical difference in a/A $PO_2$(P<0.05). We could observe changes of VI and a/A $PO_2$ within 72 hours have been continuously improved at group S rather than group M. In spite of relapses, group M changed for the better after second dose. There were also no significant differences between the two groups in duration of ventilator therapy, mortality within 28 days after birth, intraventricular hemorrhage by complication, retinopathy of premature, necrotizing enterocolitis, chronic lung diseases, sepsis, and DIC. Conclusion : In these relapse cases, as there were no significant differences in the mortality rate and the occurence of complication between group S and group M, the requirement of multiple-dose PS replacement therapy which brought improvement of prognosis was emphasized.
Keywords
Multiple-dose surfactant replacement therapy; Respiratory distress syndrome;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bizzarro MJ, Gross I. Effects of hormones on fetal lung development. Obstet Gynecol Clin N Am 2004;31:949-61   DOI   ScienceOn
2 Gilstrap LC, Christensen R, Clewell WH. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-8   DOI   PUBMED   ScienceOn
3 The Texas neonatal research group. Early surfactant for neonates with mild to moderate respiratory distress syndrome : A multicenter randomized trial. J Pediatr 2004;144:804-8
4 Speer CP, Robertoson B, Curstedt T. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome : Single versus multiple doses of Curosurf. Pediatrics 1992;89:13-20
5 Hoekstra RE, Jackson JC, Myers TF. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics 1991;88:10-8
6 Edward AL, Edward D, Dilip P, Joseph G, Bernard F, Akihiko N, et al. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics 1991;88:19-28
7 No. 229 Drug for respiratory system; lung surfactant. Korea ministry of health and welfare noticification 2000-73, 2001/01/01
8 Bomsel F. Contribution a letube radiologique de la maladiae des membranes hyalines. A propos de 110 cas. J Radiol Electrol Med Nucl 1970;51:259-68
9 Gortner L, Wauer RR, Hammer H. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age : A multicenter controlled clinical trial. Pediatrics 1998;102:1153-60.   DOI   ScienceOn
10 Kendig JW, Ryan RM, Sinkin RA. Comparison of two strategies for surfactant prophylaxis in very premature infants : A multicenter randomized trial. Pediatrics 1998;101:1006-12   DOI   PUBMED   ScienceOn
11 Bae CW, Kim YM. Surfactant therapy for neonatal respiratory distress syndrome : experience in Korea over 15 years. Korean J Pediatr 2004;47:940-8
12 Soll RF. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome [review]. Cochrane Database of Systematic reviews [computer file] CD000141, 2001.
13 Kattwinkel J. Surfactant : evolving issues. Clin Perinatol 1998;25:17-32
14 Fujiwara T, Konish M, Chida S, Okuyama K, Ogawa Y, Takeuchi Y, et al. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome : final analysis of a multicenter, double-blind, randomized trials and comparison with similar trials. Pediatrics 1990;86:753-64
15 Hallman M, Merritt TA, Bry K. The fate of exogenous surfactant in neonates with respiratory distress syndrome. Clin Pharmacokinet 1994;26:215-32   DOI   ScienceOn
16 Robertoson B, Halliday HL. Principles of surfactant replacement. Biochimica et Biophysica Acta 1998;1408:346-61   DOI   ScienceOn
17 Dunn MS, Shennan AT, Possmayer F. Single-versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks gestation with respiratory distress syndrome. Pediatrics 1990;86:564-71
18 Spafford PS, Kendig JW, Maniscalo WM. Use of natural surfactants to prevent and treat respiratory distress syndrome. Semin Perinatol 1993;17:285-94
19 Morley CJ. Systematic review of prophylactic vs rescue surfactant. Arch Dis Child 1997;77:F70-4   DOI
20 Herting E, Speer CP, Harms K, Robertoson B, Curstedt T, Halliday HL, et al. Factors influencing morbidity and mortality in infants with severe respiratory distress syndrome treated with single or multiple doses of a natural porcine surfactant. Biol Neonate 1992;61(suppl 1):26-30   DOI   PUBMED
21 Kattwinkel J, Bloom BT, Delmore P. High-versus lowthreshold surfactant retreatment for neonatal respiratory distress syndrome. Pediatrics 2000;25:17-32
22 Horbar JD, Carpenter JH, Buzas J, Soll RF, Suresh GK, Bracken MB, et al. Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation : Is routine practice evidence based? Pediatrics 2004;113:1593-602   DOI   PUBMED   ScienceOn
23 Dunn MS, Shennan AT, Zayack D. Bovine surfactant replacement therapy : A comparison of 2 retreatment strategies in premature infants with RDS[abstract]. Pediatr Res 1991;29:212A.
24 Suresh GK, Soll RF. Current surfactant use in premature infants. Clin Perinatol 2001;28:671-94   DOI   ScienceOn
25 Jobe AH. Pulmonary surfactant therapy. N Engl J Med 1993;328:861-8   DOI   ScienceOn